Venus Concept Inc. reported earnings results for the fourth quarter and full year ended December 31, 2024. For the fourth quarter, the company reported sales was USD 2.53 million compared to USD 6.06 million a year ago. Revenue was USD 15.77 million compared to USD 18.13 million a year ago. Net loss was USD 7.97 million compared to USD 11.12 million a year ago. Basic loss per share from continuing operations was USD 11.23 compared to USD 20.14 a year ago. Diluted loss per share from continuing operations was USD 11.23 compared to USD 20.14 a year ago. For the full year, sales was USD 13.27 million compared to USD 20.5 million a year ago. Revenue was USD 64.83 million compared to USD 76.35 million a year ago. Net loss was USD 47 million compared to USD 37.25 million a year ago. Basic loss per share from continuing operations was USD 71.21 compared to USD 68.47 a year ago. Diluted loss per share from continuing operations was USD 71.21 compared to USD 68.47 a year ago.
Venus is a Canada-based medical device company that develops invasive and non-invasive medical aesthetic and hair restoration systems for the healthcare industry.